Equities Analysts Offer Predictions for McKesson Q3 Earnings

Key Points

• McKesson Corporation has seen an increase in Q3 2026 earnings estimates, with analysts projecting earnings per share to rise to $9.77, up from $9.74.
• Despite a reported EPS of $8.26 in the latest quarter, McKesson missed the consensus estimate by $0.07, although revenue increased significantly by 23.4% year-over-year, totaling $97.83 billion.
• The company has also raised its quarterly dividend from $0.71 to $0.82 per share, indicating a commitment to return value to shareholders.

McKesson Corporation (NYSE:MCK - Free Report) - Equities researchers at Leerink Partnrs increased their Q3 2026 earnings estimates for shares of McKesson in a report issued on Thursday, August 7th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $9.77 per share for the quarter, up from their previous forecast of $9.74. The consensus estimate for McKesson's current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson's FY2026 earnings at $37.54 EPS, FY2027 earnings at $42.42 EPS and FY2028 earnings at $48.15 EPS.

Several other research analysts also recently weighed in on the company. UBS Group boosted their target price on McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Morgan Stanley reiterated an "overweight" rating and issued a $810.00 price objective (up previously from $770.00) on shares of McKesson in a report on Wednesday, July 16th. Bank of America lifted their price target on McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Cowen reaffirmed a "buy" rating on shares of McKesson in a research report on Thursday, August 7th. Finally, Evercore ISI increased their price target on shares of McKesson from $760.00 to $800.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and an average price target of $718.73.

McKesson Stock Down 2.1%

Shares of MCK stock traded down $13.99 on Friday, hitting $658.78. The stock had a trading volume of 1,644,064 shares, compared to its average volume of 899,068. McKesson has a one year low of $464.42 and a one year high of $737.89. The business has a 50 day moving average price of $713.17 and a 200 day moving average price of $680.90. The company has a market cap of $81.94 billion, a PE ratio of 26.27, a P/E/G ratio of 1.32 and a beta of 0.50.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.33 by ($0.07). The business had revenue of $97.83 billion for the quarter, compared to analysts' expectations of $95.93 billion. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The firm's quarterly revenue was up 23.4% on a year-over-year basis. During the same quarter last year, the firm earned $7.88 EPS.

Institutional Investors Weigh In On McKesson

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Capital A Wealth Management LLC purchased a new position in McKesson during the fourth quarter valued at approximately $26,000. Solstein Capital LLC lifted its holdings in shares of McKesson by 171.4% during the second quarter. Solstein Capital LLC now owns 38 shares of the company's stock worth $28,000 after buying an additional 24 shares during the last quarter. Bank of Jackson Hole Trust raised its position in shares of McKesson by 64.3% during the first quarter. Bank of Jackson Hole Trust now owns 46 shares of the company's stock valued at $29,000 after buying an additional 18 shares during the last quarter. CBIZ Investment Advisory Services LLC boosted its stake in McKesson by 1,366.7% during the first quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company's stock worth $30,000 after buying an additional 41 shares in the last quarter. Finally, GFG Capital LLC acquired a new position in shares of McKesson in the 2nd quarter worth approximately $30,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $726.51, for a total transaction of $394,494.93. Following the completion of the transaction, the chief accounting officer directly owned 1,972 shares in the company, valued at approximately $1,432,677.72. This represents a 21.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Brian S. Tyler sold 19,371 shares of the business's stock in a transaction that occurred on Friday, July 11th. The shares were sold at an average price of $708.09, for a total value of $13,716,411.39. Following the completion of the sale, the chief executive officer owned 27,872 shares of the company's stock, valued at $19,735,884.48. This trade represents a 41.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 52,817 shares of company stock worth $37,461,210 over the last three months. Insiders own 0.08% of the company's stock.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd will be issued a $0.82 dividend. The ex-dividend date is Tuesday, September 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.5%. This is an increase from McKesson's previous quarterly dividend of $0.71. McKesson's dividend payout ratio (DPR) is presently 11.32%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.